You may also like
Hyperthermic Perfusion as Treatment Modality for Oncological Procedures: Present and Future Perspectives (EP Video)
Peter Van den Barselaar discusses the use of hyperthermic perfusion for various oncological procedures (18:11 minutes).
1 min read
The Risk Associated with Aprotinin in Cardiac Surgery
In this observational study involving 4374 patients undergoing revascularization, we prospectively assessed three agents (aprotinin [1295 patients], aminocaproic acid [883], and tranexamic acid [822]) as compared with no agent (1374 patients) with regard to serious outcomes by propensity and multivariable methods.
1 min read
A Century of Heparin
The year 2018 was the centennial of the naming of heparin by Emmett Holt and William Howell and the 102nd anniversary of Jay McLean’s discovery of an anticoagulant heparphosphatide at Johns Hopkins Hospital in Baltimore.
1 min read